TrialBreast cancer research and treatment2023

Pyrotinib combined with trastuzumab and chemotherapy for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: a single-arm exploratory phase II trial.

Xiao-Feng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.